341 related articles for article (PubMed ID: 31947880)
41. Characterization of epiphycan, a small proteoglycan with a leucine-rich repeat core protein.
Johnson HJ; Rosenberg L; Choi HU; Garza S; Höök M; Neame PJ
J Biol Chem; 1997 Jul; 272(30):18709-17. PubMed ID: 9228042
[TBL] [Abstract][Full Text] [Related]
42. Leucine-rich repeat glycoproteins of the extracellular matrix.
Hocking AM; Shinomura T; McQuillan DJ
Matrix Biol; 1998 Apr; 17(1):1-19. PubMed ID: 9628249
[TBL] [Abstract][Full Text] [Related]
43. Osteoadherin serves roles in the regulation of apoptosis and growth in MC3T3‑E1 osteoblast cells.
Hamaya E; Fujisawa T; Tamura M
Int J Mol Med; 2019 Dec; 44(6):2336-2344. PubMed ID: 31638177
[TBL] [Abstract][Full Text] [Related]
44. Tendon proteoglycans: biochemistry and function.
Yoon JH; Halper J
J Musculoskelet Neuronal Interact; 2005 Mar; 5(1):22-34. PubMed ID: 15788868
[TBL] [Abstract][Full Text] [Related]
45. Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.
Frikeche J; Maiti G; Chakravarti S
Exp Eye Res; 2016 Oct; 151():142-9. PubMed ID: 27569372
[TBL] [Abstract][Full Text] [Related]
46. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype.
Kinsella MG; Bressler SL; Wight TN
Crit Rev Eukaryot Gene Expr; 2004; 14(3):203-34. PubMed ID: 15248816
[TBL] [Abstract][Full Text] [Related]
47. Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I.
Heppner JM; Zaucke F; Clarke LA
Mol Genet Metab; 2015 Feb; 114(2):146-55. PubMed ID: 25410057
[TBL] [Abstract][Full Text] [Related]
48. Different usage of the glycosaminoglycan attachment sites of biglycan.
Kresse H; Seidler DG; Muller M; Breuer E; Hausser H; Roughley PJ; Schonherr E
J Biol Chem; 2001 Apr; 276(16):13411-6. PubMed ID: 11145959
[TBL] [Abstract][Full Text] [Related]
49. Proteoglycans and diseases of soft tissues.
Halper J
Adv Exp Med Biol; 2014; 802():49-58. PubMed ID: 24443020
[TBL] [Abstract][Full Text] [Related]
50. Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance.
Appunni S; Rubens M; Ramamoorthy V; Anand V; Khandelwal M; Sharma A
Mol Cell Biochem; 2021 Nov; 476(11):3935-3950. PubMed ID: 34181183
[TBL] [Abstract][Full Text] [Related]
51. Canine tissue-specific expression of multiple small leucine rich proteoglycans.
Yang CH; Culshaw GJ; Liu MM; Lu CC; French AT; Clements DN; Corcoran BM
Vet J; 2012 Aug; 193(2):374-80. PubMed ID: 22365843
[TBL] [Abstract][Full Text] [Related]
52. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.
Sjöberg AP; Manderson GA; Mörgelin M; Day AJ; Heinegård D; Blom AM
Mol Immunol; 2009 Feb; 46(5):830-9. PubMed ID: 18962898
[TBL] [Abstract][Full Text] [Related]
53. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases.
Ameye L; Young MF
Glycobiology; 2002 Sep; 12(9):107R-16R. PubMed ID: 12213783
[TBL] [Abstract][Full Text] [Related]
54. Regional contribution of proteoglycans to the fracture toughness of the dentin extracellular matrix.
Alania Y; Creighton J; Trevelin LT; Zamperini CA; Bedran-Russo AK
J Biomech; 2020 Mar; 101():109633. PubMed ID: 32035660
[TBL] [Abstract][Full Text] [Related]
55. Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.
Nastase MV; Iozzo RV; Schaefer L
Biochim Biophys Acta; 2014 Aug; 1840(8):2460-70. PubMed ID: 24508120
[TBL] [Abstract][Full Text] [Related]
56. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans.
Iozzo RV; Schaefer L
FEBS J; 2010 Oct; 277(19):3864-75. PubMed ID: 20840584
[TBL] [Abstract][Full Text] [Related]
57. The origins and developments of sulfation-prone tyrosine-rich and acidic N- and C-terminal extensions of class ll and lll small leucine-rich repeat proteins shed light on connective tissue evolution in vertebrates.
Jensen MM; Karring H
BMC Evol Biol; 2020 Jun; 20(1):73. PubMed ID: 32576155
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of hydroxyapatite crystal growth by bone proteoglycans and proteoglycan components.
Rees SG; Shellis RP; Embery G
Biochem Biophys Res Commun; 2002 Apr; 292(3):727-33. PubMed ID: 11922626
[TBL] [Abstract][Full Text] [Related]
59. The matricellular functions of small leucine-rich proteoglycans (SLRPs).
Merline R; Schaefer RM; Schaefer L
J Cell Commun Signal; 2009 Dec; 3(3-4):323-35. PubMed ID: 19809894
[TBL] [Abstract][Full Text] [Related]
60. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix.
Reardon AJ; Le Goff M; Briggs MD; McLeod D; Sheehan JK; Thornton DJ; Bishop PN
J Biol Chem; 2000 Jan; 275(3):2123-9. PubMed ID: 10636917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
